Skip to main content
. 2021 Jan 29;11(1):e2021155. doi: 10.5826/dpc.1101a155

Figure 1.

Figure 1

The most common skin toxicities during the course of immunotherapy include (A) maculopapular, (B) psoriasiform and (C) lichenoid eruptions.